Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 20425403)


Acute myeloid leukemia: when to transplant in first complete remission.

Hill BT, Copelan EA.

Curr Hematol Malig Rep. 2010 Apr;5(2):101-8. doi: 10.1007/s11899-010-0042-1. Review.


Postremission therapy for acute myeloid leukemia in the first remission.

Kim ST, Jung CW, Lee J, Kwon JM, Oh SY, Park BB, Lee HR, Kim HJ, Kim K, Kim WS, Ahn JS, Kang WK, Park K.

Leuk Lymphoma. 2007 May;48(5):937-43.


Stem cell transplantation in acute myelogenous leukemia in first remission: what are the options?

Mathews V, DiPersio JF.

Curr Hematol Rep. 2004 Jul;3(4):235-41. Review.


A systematic overview of chemotherapy effects in acute myeloid leukaemia.

Kimby E, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):231-52. Review.


Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.

Chantry AD, Snowden JA, Craddock C, Peggs K, Roddie C, Craig JI, Orchard K, Towlson KE, Pearce RM, Marks DI; BSBMT Clinical Trials Committee.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1310-7.


Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia.

Hamadani M, Mohty M, Kharfan-Dabaja MA.

Cancer Control. 2011 Oct;18(4):237-45. Review.


[Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].

Wang HH, Feng SZ, Wang M, Wei JL, Jiang EL, Zhang L, Huang Y, Zhou SY, Liu QG, Qiu LG, Han MZ, Yan WW.

Zhonghua Xue Ye Xue Za Zhi. 2004 Jul;25(7):389-92. Chinese.


Acute myeloid leukemia.

Stone RM, O'Donnell MR, Sekeres MA.

Hematology Am Soc Hematol Educ Program. 2004:98-117. Review.


Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.

Hsieh YY, Hong YC, Hsiao LT, Yu YB, Liu JH, Gau JP, Lin HN, Hsu YN, Chiou TJ, Chen PM, Tzeng CH, Liu CY.

Eur J Haematol. 2011 Mar;86(3):237-45. doi: 10.1111/j.1600-0609.2010.01560.x. Epub 2011 Jan 11.


Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR.

Blood. 2000 Dec 15;96(13):4075-83.


The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission.

Huang XJ, Zhu HH, Chang YJ, Xu LP, Liu DH, Zhang XH, Jiang B, Jiang Q, Jiang H, Chen YH, Chen H, Han W, Liu KY, Wang Y.

Blood. 2012 Jun 7;119(23):5584-90. doi: 10.1182/blood-2011-11-389809. Epub 2012 Apr 24.


Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.

Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, PĂ©rez WS, Rowe JM, Wetzler M, Weisdorf DJ.

Blood. 2007 Jul 1;110(1):409-17. Epub 2007 Mar 20.


Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.

Blaise D, Vey N, Faucher C, Mohty M.

Haematologica. 2007 Apr;92(4):533-41. Review.


Fludarabine/intermediate-dose cytarabine with or without allogeneic hematopoietic stem cell transplantation in poor-risk leukemia: a single center experience.

Auberger J, Clausen J, Willenbacher W, Erdel M, Gunsilius E, Petzer A, Gastl G, Nachbaur D.

Int J Hematol. 2008 May;87(4):382-6. doi: 10.1007/s12185-008-0084-5.


Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine.

Visani G, Olivieri A, Malagola M, Brunori M, Piccaluga PP, Capelli D, Pomponio G, Martinelli G, Isidori A, Sparaventi G, Leoni P.

Leuk Lymphoma. 2006 Jun;47(6):1091-102.


A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.

Grigg AP, Gibson J, Bardy PG, Reynolds J, Shuttleworth P, Koelmeyer RL, Szer J, Roberts AW, To LB, Kennedy G, Bradstock KF.

Biol Blood Marrow Transplant. 2007 May;13(5):560-7. Epub 2007 Feb 22.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk